Press Releases

5 March 2008	PanGenetics raises 23 million Euro in a series C financing to fund clinical advancement of its therapeutic antibody programs
8 December 2006	Jan van Heek joins PanGenetics' Supervisory Board
7 December 2006	PanGenetics BV licenses therapeutic antibody for the treatment of pain from Lay Line Genomics S.p.A
30 November 2006	PanGenetics BV licenses therapeutic antibody from Schering-Plough Corporation
27 March 2006	PanGenetics BV Closes Series B Financing and Announces Board Appointments
8 September 2005	PanGenetics BV Closes $2m Seed Financing from Index Ventures